Between February 2001 and March 2002, Gary McKinnon says he accessed unsecured U.S. government computers and found a document titled “non-terrestrial officers.” He claimed it listed “fleet-to-fleet ...
Peer To Peer Network, through its AI division, PTOP Intelligence Labs, secured a strategic technology partnership to accelerate the deployment of its Tier-1 AI investor-relations solution. PTOP ...
In risk groups defined by American Urologic Association criteria, recurrences were reported in 8.9% of patients of the low-risk group, 11% of patients in the intermediate-risk group, 22% of those in ...
President Donald Trump on Tuesday announced that the U.S. will designate Saudi Arabia a major non-NATO ally, unveiling a defense and economic partnership with Crown Prince Mohammed bin Salman during a ...
Adding one year of IMFINZI treatment to Bacillus Calmette-Guérin (BCG) induction and maintenance therapy delivered an early and sustained disease-free survival benefit vs. BCG alone WILMINGTON, Del.-- ...
CEO Mark Adams described fiscal 2025 as a "transformational year" marked by a 17% top-line growth, 190 basis points of non-GAAP operating margin expansion, and a 53% increase in non-GAAP diluted EPS.
The United States was among 10 states that voted against a non-binding resolution for a two-state solution to the Israeli-Palestinian conflict on Friday at the U.N. General Assembly. A resolution ...
Please provide your email address to receive an email when new articles are posted on . The guidelines address issues related to development and prescription of non-opioid pain drugs. They are part of ...
Salt River Project (SRP) and Google this week announced what the companies are calling a “first-of-its-kind” research collaboration to better understand the real-world performance of emerging ...
McNees Government Relations (McNees GR) announced that energy lobbyist and attorney Michael Killion has joined the firm as vice president, bolstering its growing government affairs and policy team.
Physiologically Based Pharmacokinetic Model to Assess the Drug-Drug-Gene Interaction Potential of Belzutifan in Combination With Cyclin-Dependent Kinase 4/6 Inhibitors A total of 14,177 patients were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results